Hospital pharmacists protest higher cancer drug costs in survey

A national survey of pharmacy professionals released March 3 found that a move to specialty drug distribution of 3 primary cancer drugs is resulting in higher costs to hospitals and reduced availability of the medications. » Survey details

FDA approves additional indication for Opdivo

FDA has expanded the approved use of nivolumab (Opdivo, Bristol-Myers Squibb) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. » More

Continuing Education

New and emerging therapies for the treatment of diabetes

This month and next month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss new and emerging medications for the treatment of diabetes.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT15-WKX27.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

Drugs in Perspective: Lemtrada (alemtuzumab)

Lemtrada (alemtuzumab) received FDA approval on November 14, 2014, under fast track designation, for the treatment of patients with relapsing forms of MS. » Clinical studies, cost details.

POLL:

A new class of biologics in the PCSK9 Inhibitors likely will be approved for treating high cholesterol. How are you preparing?

• 7 strategies for managing the rise in specialty drug costs

• New treatment for advanced melanoma approved by FDA

RESOURCES

Latest Clinical News